| Serial Number | 97203147 |
| Word Mark | LIBRA SCIENCES |
| Filing Date | Wednesday, January 5, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, April 26, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of a pattern series of colored dots and beads, in the shades of khaki, pastel orange, pastel red, pastel blue, pastel pink, and pastel magenta, to the left of the mark. The patterns together form a device element that gives the impression of a section of a nucleic acid double helix structure. To the right of said device element is the bolded and stylized word 'LIBRA', fully capitalized in khaki. Underneath the word 'LIBRA' is the word 'SCIENCES' in a smaller font, also in khaki. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark. |
| Goods and Services | Pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of diseases and disorders relating to women's health, namely, gynecological diseases and disorders, endometrial disease and disorders; pharmaceutical products and preparations and traditional Chinese medicine for the treatment of orthopedic injuries and conditions; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of ophthalmological diseases, conditions and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of neurological diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities |
| Indication of Colors claimed | The color(s) khaki, pastel orange, pastel red, pastel blue, pastel pink, and pastel magenta is/are claimed as a feature of the mark. |
| Goods and Services | Consulting for pharmacology and medical toxicology in the fields of gastrointestinal medicine, women's health, orthopedics and ophthalmology; consulting for pharmacology and toxicology in the field of neurodegenerative diseases and disorders |
| Goods and Services | Providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from gastro-intestinal diseases and disorders, diseases and disorders relating to woman's health, orthopedics and orthopedic injuries and conditions, and ophthalmological diseases, conditions and disorders; medical testing for diagnostic or treatment purposes in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders; pre-clinical and clinical services for pharmaceutical and diagnostic test formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; pre-clinical and clinical services for formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the field of neurodegenerative diseases |
| Goods and Services | Surgical apparatus and instruments for use in the field of gastro-intestinal medicine, orthopedics and ophthalmology; Medical apparatus and instruments, namely, surgical robotic apparatus and non-invasive detection tools in the nature of medical imaging devices for detecting brain plaques; medical and surgical apparatus, instruments and parts therefor for use in magnetic resonance imaging and other imaging-guided surgery, including markers for use in patient registration in the nature of procedures used in computer assisted surgeries and tracking the location of instruments within the patient's body during image guided surgeries; medical and surgical apparatus, instruments and parts therefor for use in minimum invasive surgery; medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articles, namely, analytical apparatus for diagnosis of neurodegenerative diseases; analysis apparatus for medical purposes, namely, non-invasive detection apparatus probes and imaging devices for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposes, for diagnosing plagues and images in brain for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficiencies, neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities |
| Disclaimer with Predetermined Text | "SCIENCES" |
| Goods and Services | Conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; scientific and toxicology research services in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; biopharmaceutical research for development of targeted therapies for use in the treatment of gastrointestinal diseases and disorders, diseases and disorders relating to woman's health, orthopedics and orthopedic injuries and conditions, and ophthalmological diseases conditions and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of gastrointestinal medicine, women's health, orthopedics and ophthalmology; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 18, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 10, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Libra Sciences Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Hong Kong HK |
| Event Date | Event Description |
| Wednesday, April 26, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, April 26, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, April 26, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, January 10, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 10, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, January 10, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, November 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 17, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 17, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 24, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 24, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, October 24, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 12, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, January 11, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, January 10, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 8, 2022 | NEW APPLICATION ENTERED |